SPL AU000000SPL0

Report

Delayed Australian Stock Exchange - 05/16 02:11:02 am EDT
0.8100	AUD		+3.85%

04/28	STARPHARMA : Quarterly Cashflow and Activities Report	PU
03/31	Starpharma Holdings Limited Appoints Jeff Davies as Director	CI
03/31	Starpharma's Viraleze Antiviral Nasal Spray to Relaunch in the UK; Shares Jump 7%	MT

Starpharma : Secures Supply Orders for Nasal Spray Product in Vietnam

10/26/2021 | 03:55am EDT

All news about STARPHARMA HOLDINGS LIMITED

04/28	STARPHARMA : Quarterly Cashflow and Activities Report	PU
03/31	Starpharma Holdings Limited Appoints Jeff Davies as Director	CI
03/31	Starpharma's Viraleze Antiviral Nasal Spray to Relaunch in the UK; Shares Jump 7%	MT
03/31	Starpharma Holdings Limited Announces Relaunch of VIRALEZETM in UK	CI
03/20	STARPHARMA HOLDINGS LIMITED(ASX : SPL) added to S&P/ASX Emerging Companies Index	CI
03/16	STARPHARMA : Application for quotation of securities - SPL	PU
03/01	Starpharma's Antiviral Agent in Viraleze Found to Lower Omicron Virus Infectivity by ov..	MT
02/28	Starpharma Announces SPL7013 in Viraleze Virucidal Against Omicron	CI
02/23	Starpharma Holdings Limited Appoints Jeff Davies as Non-Executive Director, Effective 1..	CI
02/21	Starpharma Holdings Narrows Fiscal H1 Loss on Higher Revenue	MT

Financials

Chart STARPHARMA HOLDINGS LIMITED

Duration : Period :

Technical analysis trends STARPHARMA HOLDINGS LIMITED

	Short Term	Mid-Term	Long Term
Trends	Bearish	Bearish	Bearish

Income Statement Evolution

More Financials

Managers and Directors

Jacinth K. Fairley	Chief Executive Officer & Executive Director
Nigel J. Baade	Financial Controller
Robert Bain Thomas	Non-Executive Chairman
David J. Owen	Vice President-Research
Zita Peach	Independent Non-Executive Director

Sector and Competitors

		1st jan.	Capi. (M$)
	STARPHARMA HOLDINGS LIMITED	-41.79%	220

STARPHARMA HOLDINGS LIMITED